🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today we reported third quarter 2023 #Earnings Results, returning to topline growth and tightening guidance for the year. Read the full press release: bit.ly/461rOcj

Today, $ELAN reported fourth quarter and full year 2023 #Earnings Results, announcing a return to topline growth for the full year, setting the stage for continued revenue growth in 2024. Read the full press release, bit.ly/3SKwles

Elanco (NYSE: ELAN) Beats Q1 2024 Expectations, Raises FY 2024 Constant Currency Revenue Growth Guidance. Click here to read the full earnings press release: bit.ly/3QFsqiX

Today Elanco provided a progress update as we continue to advance our historic innovation pipeline. bit.ly/45IAXIg

We announced today we have completed the divestiture of our aqua business to Merck Animal Health for approximately $1.3 billion in cash, with approximately $1.05-$1.1 billion in net proceeds available for debt paydown in the third quarter of 2024. bit.ly/3RVc3Q8

Today, we reported second quarter 2024 financial results, marking our fourth consecutive quarter of underlying revenue growth, and beating guidance in all our key financial metrics. bit.ly/3LUuFfo

Though shares of $ELAN are down 30% from its 52-week highs, Elanco CEO Jeff Simmons has an optimistic tone as the company is set to launch one new product in each of the next three quarters across two new markets 🐶 Simmons tells Oliver Renick what’s coming down the pike:

Our President and CEO Jeff Simmons joined @SchwabTV to share his optimism for all that is to come – with not one but three potential blockbuster products coming down the pike. Thanks for having us, Oliver Renick - we are excited to lead the future of animal health. #WeAreElanco

Thanks for having us on, AgriNovus Indiana! We're excited about the future of the animal health industry as we approach the next wave of innovation.

Today, we announced that Credelio Quattro, our broad-spectrum parasiticide, is moving to the Food and Drug Administration (FDA) final 60-day administrative review phase. U.S. approval is expected in October 2024 and launch expected in Q1 2025. Read more: bit.ly/3SUgye2

Thanks for featuring us! We're thrilled about the role we'll play in the future of the animal health industry.

Exciting day as we achieve another milestone in our innovation pipeline with FDA approval of our new dermatology product. bit.ly/Zenrelia #WeAreElanco

Our president and CEO, Jeff Simmons, joined state agriculture leaders at the NASDA conference! The panel, also featuring @Corteva and AgriNovus Indiana, discussed evolving innovations and groundbreaking technologies in #agbioscience #climateweek

Cows and #ClimateWeek can co-exist. Earlier this year, we experienced the warmest day in Earth's recorded history. The most efficient opportunity to mitigate warming? Methane. Check out a conversation with our CEO and a leading climate expert to learn more bit.ly/3R4aDBj

Today, we announced our Q3 2024 $Elan earnings, highlighting our 5th consecutive quarter of underlying business growth with expected momentum to accelerate into 2025. Read more: bit.ly/4hEJwt0 #WeAreElanco #AnimalHealth #Innovation #Earnings

Today, we announced the appointment of Dr. Stacey Ma to our Board of Directors. Dr. Ma brings extensive experience in biopharmaceutical development and manufacturing, further strengthening our expertise in these areas. Learn more: bit.ly/4fo5hvF

Thanks for the spotlight! We're proud to collaborate with the Protein PACT and industry partners to support healthy animals, because making life better for animal makes life better!

Thanks for the partnership and helping represent the livestock industry at COP29!

Today, $ELAN reported fourth quarter and full year 2024 #Earnings Results, delivering our sixth consecutive quarter of organic constant currency revenue growth, setting the stage for continued acceleration in 2025. Read the full press release, bit.ly/4gRgmWh .

Today $ELAN reported first quarter 2025 #Earnings Results, outperforming expectations across our key metrics and delivering our seventh consecutive quarter of organic constant currency revenue growth at 4%. Read the full press release: bit.ly/44w8uad